MAA
ABBV icon

Mraz Amerine & Associates’s AbbVie ABBV Stock Holding History

Mraz Amerine & Associates’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-14,026
Closed -$741K – 144
2013
Q4 		$741K Sell
14,026
-2,325
-14% -$114K 0.33% 50
2013
Q3 		$731K Sell
16,351
-22,294
-58% -$988K 0.35% 48
2013
Q2 		$1.6M Buy
+38,645
New +$1.69M 0.81% 25

Other funds holding ABBV

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Mraz Amerine & Associates's ABBV Position: Q1 2014 in Review

Mraz Amerine & Associates sold out of AbbVie (ABBV) in Q1 2014, closing a stake of 14,026 shares — an estimated $741K sold.

Mraz Amerine & Associates first reported a position in ABBV in Q2 2013 and held it in 3 quarters. The position peaked at $1.6M in Q2 2013. 1,422 funds tracked by Wall St. Rank hold ABBV as of Q1 2014.

  • Mraz Amerine & Associates reported no remaining AbbVie position as of Q1 2014 after selling out during the quarter.
  • Mraz Amerine & Associates sold 14,026 AbbVie shares in Q1 2014, an estimated $741K.
  • Mraz Amerine & Associates first reported a position in AbbVie in Q2 2013 and held it in 3 quarters.
  • Mraz Amerine & Associates's AbbVie position peaked at $1.6M in Q2 2013.
  • 1,422 funds tracked by Wall St. Rank held AbbVie as of Q1 2014.

Based on Mraz Amerine & Associates's 13F filing for Q1 2014, filed 9 May 2014.